Abstract
Lung cancer has been recognized as the most important reason for death and a lifethreatening disease. The late diagnosis of this disease usually limits treatment interventions. The lack of reliable noninvasive biomarkers and therapies results in low survival rates. The current review is designed to uncover the specific role of biomarker genes involved in the non-small cell lung cancer (NSCLC) and demonstrate their high discrimination power between NSCLC from the normal tissues. So, studying the gene expression differences associated with their network functionality extracted from the serum biomarkers will be a helpful approach in predicting them on small cell lung cancer. Nowadays, several analyses based on bioinformatics and computational methodologies have determined various genes influencing the healthy and diseased cells for achieving a better performance on treatment and prognosis of NSCLC. Although the existing treatments for all stages of lung cancer including surgery, chemotherapy, or radiation did not show reasonable results, achieving better outcomes in the future may be possible through genetic diagnosis as well as gene therapy techniques.
Keywords: Bioinformatics analyses, biomarker, diagnosis, gene, lung cancer, treatment.
Current Respiratory Medicine Reviews
Title:The Role of Biomarker Genes in the Diagnosis and Treatment of Nonsmall Cell Lung Cancer
Volume: 14 Issue: 3
Author(s): Massoud Sokouti, Mohsen Sokouti and Babak Sokouti*
Affiliation:
- Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz,Iran
Keywords: Bioinformatics analyses, biomarker, diagnosis, gene, lung cancer, treatment.
Abstract: Lung cancer has been recognized as the most important reason for death and a lifethreatening disease. The late diagnosis of this disease usually limits treatment interventions. The lack of reliable noninvasive biomarkers and therapies results in low survival rates. The current review is designed to uncover the specific role of biomarker genes involved in the non-small cell lung cancer (NSCLC) and demonstrate their high discrimination power between NSCLC from the normal tissues. So, studying the gene expression differences associated with their network functionality extracted from the serum biomarkers will be a helpful approach in predicting them on small cell lung cancer. Nowadays, several analyses based on bioinformatics and computational methodologies have determined various genes influencing the healthy and diseased cells for achieving a better performance on treatment and prognosis of NSCLC. Although the existing treatments for all stages of lung cancer including surgery, chemotherapy, or radiation did not show reasonable results, achieving better outcomes in the future may be possible through genetic diagnosis as well as gene therapy techniques.
Export Options
About this article
Cite this article as:
Sokouti Massoud , Sokouti Mohsen and Sokouti Babak *, The Role of Biomarker Genes in the Diagnosis and Treatment of Nonsmall Cell Lung Cancer, Current Respiratory Medicine Reviews 2018; 14 (3) . https://dx.doi.org/10.2174/1573398X15666181219113646
DOI https://dx.doi.org/10.2174/1573398X15666181219113646 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Bcl-2 Targeted-Therapy for the Treatment of Head and Neck Squamous Cell Carcinoma
Recent Patents on Anti-Cancer Drug Discovery NF-κ B and Rheumatic Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Recognition of Lung Adenocarcinoma-specific Gene Pairs Based on Genetic Algorithm and Establishment of a Deep Learning Prediction Model
Combinatorial Chemistry & High Throughput Screening Phage Display Applications for Molecular Imaging
Current Pharmaceutical Biotechnology Fluorescent Cisplatin Analogues and Cytotoxic Activity
Current Medicinal Chemistry Drug Analogs of COX-2 Selective Inhibitors Lumiracoxib and Valdecoxib Derived from in silico Search and Optimization
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Urokinase-type Plasminogen Activator and the Generation of Inhibitors of Urokinase Activity and Signaling
Current Pharmaceutical Design A Review on CRISPR-mediated Epigenome Editing: A Future Directive for Therapeutic Management of Cancer
Current Drug Targets Interfering with Protein-Protein Contact: Molecular Interaction Maps and Peptide Modulators
Current Topics in Medicinal Chemistry Multifaceted Approach to Circadian Rhythm: Redox, Oxidative Stress, Melatonin, Antioxidants, Nitric Oxide, Hypoxia, Anesthetics, Cortisol and Cocaine
Current Chemical Biology Exploiting Cyclooxygenase-(in)Dependent Properties of COX-2 Inhibitors for Malignant Glioma Therapy
Anti-Cancer Agents in Medicinal Chemistry Unlocking the Molecular Mechanisms of DNA Repair and Platinum Drug Resistance in Cancer Chemotherapy
Current Drug Therapy Alterations in Homocysteine Metabolism Among Alcohol Dependent Patients - Clinical, Pathobiochemical and Genetic Aspects
Current Drug Abuse Reviews The FDG-PET Revolution of Medical Imaging – Four Decades and Beyond
Current Molecular Imaging (Discontinued) Wnt Signaling in Rhabdomyosarcoma – A Potential Targeted Therapy Option
Current Drug Targets Inhibition of SOX15 Sensitizes Esophageal Squamous Carcinoma Cells to Paclitaxel
Current Molecular Medicine Current Phthalocyanines Delivery Systems in Photodynamic Therapy: An Updated Review
Current Medicinal Chemistry Editorial (Thematic Issue: Nanotechnology for Drug Delivery: Part I)
Current Pharmaceutical Design The Mechanism of Action of Praziquantel: Can New Drugs Exploit Similar Mechanisms?
Current Medicinal Chemistry Attenuation of ERK/RSK2-Driven NFκB Gene Expression and Cancer Cell Proliferation by Kurarinone, a Lavandulyl Flavanone Isolated from Sophora flavescens Ait. Roots
Endocrine, Metabolic & Immune Disorders - Drug Targets